69 of 100

69. Angiodynamics

69. Angiodynamics
Financials: Latest Results
Rank: 69 (Previous rank: N.A.)
CEO: Jan Keltjens
Headquarters: Queensbury, NY
Employees: 640
Industry: Health Care
Revenue: $180.3 million
(four quarters to 12/31/08)
Return to investors: -18.76%
(three years to 12/81/08, annualized rate)

Angiodynamics develops medical devices that enable minimally invasive treatment of cancer and peripheral vascular disease. Early this year, the company added to its product line an infusion catheter that delivers drugs through the renal arteries directly to the kidneys. Its new NanoKnife technology also holds promise for the focal treatment of cancer tumors.
From the July/August 2009 issue of Fortune Small Business magazine
Source: Zacks
Revenue is for the most recent four quarters ended on or before 12/31/08.

See Angiodynamics in...
... What Readers Say
They speak out on the fastest-growing small public companies ...
Find Business Answers
Ask a Question

Sponsored by
  • NEXT
    Finding hidden Texas oil
    A cemetery and funeral operator places #54 on FSB's list of the 100 fastest growing small public companies. Watch
Top 3

New York 13
California 10
Minnesota 9
Texas 9
Sophocles Zoullas 35.8
Scott Ginsburg 6.9
John Higginbotham 6.5
IntegraMed America 197.8
Datalink Corp. 195.6
Eagle Bulk Shipping 185.4
For our ninth annual list, we once again worked with financial research firm Zacks, which ranked public companies with revenues of less than $200 million and a stock price of more than $1... More